Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$36.95 - $82.41 $429,950 - $958,922
-11,636 Closed
0 $0
Q1 2022

Apr 08, 2022

BUY
$55.7 - $145.79 $23,783 - $62,252
427 Added 3.81%
11,636 $885,000
Q4 2021

Jan 12, 2022

BUY
$135.05 - $182.59 $138,966 - $187,885
1,029 Added 10.11%
11,209 $1.67 Million
Q3 2021

Oct 15, 2021

BUY
$145.58 - $192.14 $1.48 Million - $1.96 Million
10,180 New
10,180 $1.48 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $2.05B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.